Transient neonatal hypothyroidism due to maternal seaweed soup ingestion: a report of 3 cases Authors: Sofya Ilmer, Vivienne Lopez-Cabreza, Parissa Salemi Published: 2026 ABSTRACT AbstractSeaweed soup (miyeok-guk) is traditionally consumed daily by Korean women during pregnancy and postpartum, often resulting in maternal iodine intake exceeding 2000 µg/day, which can induce neonatal hypothyroidism (NH) in breastfed infants. Neonatal hypothyroidism refers to transient thyroid dysfunction from extrinsic iodine exposure, distinct from congenital hypothyroidism (CH) due to intrinsic thyroid defects. We present 3 infants of Korean descent with NH associated with maternal seaweed soup consumption. Case 1 is a preterm infant with severe hypothyroidism resolving rapidly after maternal discontinuation of seaweed soup, with levothyroxine discontinued at 6 months. Case 2 presented with subclinical hypothyroidism on day of life 11 and an atypical course requiring dose adjustments before proving transient at age 3.5 years. Case 3 had severe hypothyroidism at birth and was treated for 6 years as presumed CH; however, levothyroxine dose remained unchanged despite significant growth, and therapy was discontinued after maternal dietary history was obtained, confirming transient disease. These cases demonstrate that initial thyroid-stimulating hormone severity poorly predicts permanence and that levothyroxine dose trajectory is more reliable. Culturally sensitive history-taking and systematic reevaluation at age 3 can prevent unnecessary lifelong therapy. Introduction Neonatal hypothyroidism (NH) due to maternal seaweed soup consumption is a recognized phenomenon in East Asian cultures, where it is traditionally consumed during pregnancy and postpartum to promote lactation. We use “neonatal hypothyroidism” to reflect its acquired nature from extrinsic iodine exposure, distinct from congenital hypothyroidism (CH), which typically results from intrinsic thyroid defects such as thyroid dysgenesis (absent, ectopic, or hypoplastic gland) or dyshormonogenesis (defects in thyroid hormone synthesis). While CH is most often permanent and detected on newborn screening (NBS), NH caused by iodine excess is characteristically transient and resolves once the iodine source is removed, though the 2 entities may be clinically indistinguishable at initial presentation. Seaweed contains extremely high iodine concentrations, ranging from 16 µg/g in nori to over 8000 µg/g in certain kelp products, with substantial variability depending on species, geographic origin, and processing conditions [1]. Excessive maternal intake elevates breast milk iodine levels, potentially inducing hypothyroidism in susceptible neonates through the Wolff–Chaikoff effect. The American Thyroid Association recommends women ingest approximately 250 µg of iodine daily during pregnancy and lactation, cautioning that sustained intake above 500 to 1100 µg/day should be avoided [2]. However, Korean postpartum women often consume over 2000 µg/day [3-6]. Importantly, initial thyroid-stimulating hormone (TSH) severity does not reliably predict whether NH will be transient or permanent, and failure to obtain a thorough maternal dietary history may result in years of unnecessary treatment. US case reports of seaweed-induced NH remain rare, and prolonged unnecessary treatment resulting from missed dietary history has not been well described. We present 3 cases illustrating the clinical spectrum of iodine-induced NH and highlight the importance of culturally sensitive history-taking and systematic reassessment. Case presentation Case 1 A female infant born at 31 weeks gestation to a Korean-American mother presented on day of life (DOL) 29. Initial NBS on DOL 3 was normal; repeat screening on DOL 23 revealed TSH 158.9 μIU/mL (SI [International System of Units]: 158.9 mIU/L) (reference range, 0.70-11.00 μIU/mL [SI: 0.70-11.00 mIU/L]). Maternal dietary history consisted of seaweed soup 1 to 2 times daily following delivery while predominantly breastfeeding. Case 2 A full-term female infant born to a Korean-American mother who consumed seaweed soup prenatally was predominantly breastfed. Newborn screening showed slightly elevated TSH (numeric value not reported by the New York State screening program). Case 3 A full-term female infant born to a Korean-American mother had abnormal NBS showing TSH 460.3 μIU/mL (SI: 460.3 mIU/L) and total thyroxine (T4) 6.1 μg/dL (SI: 78.5 nmol/L). Diagnostic assessment Case 1 Confirmatory testing showed TSH 295 μIU/mL (SI: 295 mIU/L), free thyroxine (FT4) 0.7 ng/dL (SI: 9.0 pmol/L) (reference range, 0.9-1.8 ng/dL [SI: 11.6-23.2 pmol/L]), and T4 5.9 μg/dL (SI: 75.9 nmol/L) (reference range, 4.6-12.0 μg/dL [SI: 59.2-154.4 nmol/L]). The mother immediately discontinued seaweed soup. Case 2 Confirmatory testing on DOL 11 revealed TSH 53 μIU/mL (SI: 53 mIU/L) with normal FT4 1.2 ng/dL (SI: 15.4 pmol/L). Case 3 Evaluation on DOL 7 confirmed severe primary hypothyroidism (TSH 456 μIU/mL [SI: 456 mIU/L], T4 4.3 μg/dL [SI: 55.3 nmol/L]). Treatment Case 1 Levothyroxine 25 µg daily (12 µg/kg/day) was initiated. Case 2 Levothyroxine 37.5 µg daily (11.4 µg/kg/day) was initiated on DOL 12. Two weeks later, TSH was suppressed (0.68 μIU/mL [SI: 0.68 mIU/L]) with elevated FT4 and T4, prompting dose reduction to 25 µg daily. By 3 months, the dose was further reduced to alternating 12.5/25 µg daily (3.6 µg/kg/day). However, at 15 months, TSH rose to 6.09 μIU/mL (SI: 6.09 mIU/L), requiring a dose increase to 25 µg daily (2.0 µg/kg/day). At 33 months, TSH rose again to 8.85 μIU/mL (SI: 8.85 mIU/L), necessitating continuation of 25 µg daily (1.8 µg/kg/day). Case 3 Levothyroxine 37.5 µg daily (13 µg/kg/day) was initiated. One month later, TSH was normalized with elevated thyroid hormone levels (T4 17.7 μg/dL [SI: 227.7 nmol/L], FT4 3.3 ng/dL [SI: 42.5 pmol/L]). Her levothyroxine dose remained unchanged for 6 years despite significant growth. Outcome and follow-up Case 1 Two weeks later, TSH normalized to 0.65 μIU/mL (SI: 0.65 mIU/L) with elevated T4 and FT4, indicating rapid recovery and iatrogenic hyperthyroxinemia. Levothyroxine was progressively reduced and discontinued at 6 months. She remained euthyroid postdiscontinuation (Fig. 1A). Clinical course of 3 infants with iodine-induced neonatal hypothyroidism. Thyroid-stimulating hormone (TSH) concentrations (circles, left y-axis, logarithmic scale) and weight-based levothyroxine dose (solid line, right y-axis) are plotted against age. (A) Case 1, a preterm infant with severe hypothyroidism, shows rapid resolution and levothyroxine discontinuation by 6 months. (B) Case 2 demonstrates an atypical course with intermittent dose escalations before successful discontinuation around 4 years. (C) Case 3 shows severe initial hypothyroidism, treated for 6 years with a stable low dose before confirming transient disease. Case 2 At age 3.5 years, levothyroxine was reduced to 12.5 µg daily (0.9 µg/kg/day). Given the low-dose requirement and maternal iodine exposure history, levothyroxine was discontinued after 5 months of stable thyroid function tests (TFTs) (TSH 3.61 μIU/mL [SI: 3.61 mIU/L], FT4 1.4 ng/dL [SI: 18.0 pmol/L]). Two months postdiscontinuation, TSH rose to 7.39 μIU/mL (SI: 7.39 mIU/L) (reference range for age, 0.70-6.00 μIU/mL [SI: 0.70-6.00 mIU/L]); however, repeat testing 4 months later showed spontaneous normalization (TSH 4.16 μIU/mL [SI: 4.16 mIU/L], FT4 1.3 ng/dL [SI: 16.7 pmol/L]). She remains euthyroid off therapy (Fig. 1B). Case 3 At 6 years 2 months, after transfer to a new provider, detailed dietary history revealed maternal consumption of seaweed soup up to 4 times weekly during pregnancy and postpartum. This history, combined with lack of dose escalation, raised suspicion for transient etiology. Levothyroxine was initially tapered and eventually discontinued. Follow-up at 2 and 4 months postdiscontinuation confirmed normal TFTs. She remains euthyroid off medication (Fig. 1C). Discussion High iodine concentrations from maternal seaweed soup consumption can induce the Wolff–Chaikoff effect, where excessive intrathyroidal iodine inhibits thyroid hormone synthesis [7]. Normally, iodine is transported into thyroid cells via the sodium/iodide symporter (NIS) and organified by thyroid peroxidase (TPO) to form thyroid hormones. However, when intrathyroidal iodine levels rise sharply, organification is inhibited through suppression of hydrogen peroxide generation, which is essential for TPO activity [8]. In healthy adults, the thyroid typically “escapes” from the Wolff–Chaikoff effect within 1 to 2 weeks through downregulation of NIS expression, which reduces iodine uptake and allows hormone synthesis to resume. However, the fetal and neonatal thyroid may fail to escape this inhibitory effect, particularly in preterm infants with immature hypothalamic–pituitary–thyroid axes [9]. During pregnancy, excessive maternal iodine from seaweed soup crosses the placenta, directly exposing the fetus. Postpartum, iodine is concentrated in breast milk, leading to sustained exposure in the nursing infant and prolonged suppression of thyroid hormone synthesis [10, 11]. This explains the variable timing of presentation: prenatal exposure may cause an abnormal initial newborn screen, whereas postpartum-onset consumption may result in a normal initial screen followed by delayed hypothyroidism as iodine accumulates via breast milk. Discontinuation of maternal seaweed intake and temporary levothyroxine therapy typically leads to resolution once the iodine load clears [10]. Understanding the source of this iodine excess requires recognition of the cultural practices that drive maternal intake. Despite guideline recognition of iodine excess as a cause of transient hypothyroidism, seaweed consumption is not specifically addressed, and US case reports remain rare [10, 12]. The postpartum consumption of seaweed soup is deeply rooted in Korean and other East Asian cultures, believed to promote maternal recovery and lactation [5, 13]. While traditionally emphasized postpartum, many women begin consumption in the third trimester. Studies show over 93% of Korean postpartum women consume seaweed soup daily, with median iodine intakes exceeding 2000 to 3000 µg/day—far above the recommended upper limit of 500 to 1100 µg/day for lactating women [2, 4-6, 13]. This practice is often continued by immigrant families in the United States. The American Academy of Pediatrics (AAP) emphasizes that culturally effective care requires inquiry into traditional health practices, as they may not be spontaneously disclosed [14]. A culturally sensitive approach helps identify modifiable risk factors otherwise overlooked [15]. The cases presented illustrate this principle and demonstrate the heterogeneous outcomes of iodine-induced NH. Case 1 exemplifies preterm infant vulnerability to iodine excess. This infant had a normal initial newborn screen but developed severe hypothyroidism by DOL 23—consistent with delayed TSH elevation seen in preterm infants due to immaturity of the hypothalamic–pituitary–thyroid axis. Preterm infants have reduced thyroid reserve, diminished TSH surge at birth, and cannot escape iodine-induced inhibition as efficiently as term infants [12, 16]. This environmental trigger and developmental vulnerability caused profound but transient hypothyroidism that resolved rapidly after removing the iodine source [12, 17]. This case highlights how environmental exposures can interact with developmental immaturity to produce a phenotype mimicking permanent hypothyroidism but is reversible. Importantly, when seaweed soup consumption begins postpartum, a normal initial newborn screen does not exclude subsequent hypothyroidism. Unlike preterm infants, full-term infants do not routinely undergo repeat screening, raising concern that cases may go undiagnosed. Case 3 illustrates how delayed recognition of transient etiology can result in years of avoidable treatment. This patient received levothyroxine replacement therapy for 6 years learning of maternal seaweed soup consumption. Notably, her levothyroxine dose remained consistent, which should prompt reconsideration of the diagnosis of CH [12, 18]. The AAP recommends that if permanent CH has not been confirmed by imaging demonstrating thyroid dysgenesis or TSH elevation above 10 mIU/L during treatment, a trial off levothyroxine should be considered at 3 years of age, particularly in patients on low doses (<2 µg/kg/day) [12]. In contrast, case 2 demonstrates that prenatal iodine exposure can cause an abnormal initial newborn screen. When dietary history is obtained at presentation, it should alert clinicians to possible transient disease and prompt systematic reevaluation rather than assuming permanence. Earlier reassessment guided by maternal dietary history could have identified the transient nature of case 3 sooner. Initial TSH concentration is not predictive of permanence; permanent hypothyroidism should not be assumed solely based on very elevated TSH at diagnosis. Predictors of transient disease include low levothyroxine requirement, stable dosing over time, and absence of TSH elevation during treatment. Pediatricians should obtain detailed dietary and cultural history at diagnosis, and pediatric endocrinologists should revisit this when the clinical course suggests transient disease. Culturally sensitive history-taking, including specific inquiry about seaweed consumption, should be incorporated into routine prenatal, newborn, and postpartum care—particularly in East Asian families. Inquiry should include timing of consumption (prenatal vs postpartum) to anticipate the clinical presentation. When maternal iodine excess is identified, repeat thyroid function testing should be considered even if the initial newborn screen is normal, as delayed TSH elevation may occur as iodine accumulates via breast milk. For infants diagnosed with hypothyroidism in this context, consideration of a trial off levothyroxine at age 3 years can prevent years of unnecessary treatment. Table 1 summarizes clinical takeaways for clinicians caring for these patients. Table 1Key clinical takeaways and recommendations for iodine-induced neonatal hypothyroidismClinical domainKey takeawayRecommendationReferencesPathophysiologyExcessive iodine from seaweed soup induces the Wolff–Chaikoff effect, acutely inhibiting thyroid hormone synthesis; neonates are particularly susceptible because their immature thyroid may fail to escape this inhibition.Counsel lactating mothers to limit iodine intake to 500 to 1100 µg/day; advise discontinuation of seaweed soup if infant hypothyroidism is identified.[2, 5, 6, 11, 19, 20]Cultural awarenessPostpartum seaweed soup consumption (miyeok-guk) is a tradition in Korean and other East Asian cultures, often continued by immigrant families in the United StatesIncorporate culturally sensitive dietary history-taking into routine newborn and postpartum care; ask specifically about seaweed, kelp, or iodine-containing supplements.[13-15]Newborn screeningInitial newborn screen may be normal; delayed TSH elevation can occur days to weeks later as iodine accumulates via breast milk.Consider repeat thyroid function testing in breastfed infants of mothers with high iodine intake, even if initial newborn screen is normal; repeat screening is already recommended for preterm/LBW infants by AAP.[12, 17]Preterm vulnerabilityPreterm infants have immature hypothalamic–pituitary–thyroid axes and are at higher risk for iodine-induced hypothyroidism and delayed TSH rise.Maintain heightened vigilance for thyroid dysfunction in preterm infants exposed to maternal iodine excess; monitor closely after NICU discharge.[3, 16, 17]Distinguishing transient vs permanent NHPredictors of transient disease include low levothyroxine dose requirement (<3 µg/kg/day at 1 year, <2.5 µg/kg/day at 3 years), stable dosing over time, and absence of TSH elevation above 10 μIU/mL (SI: 10 mIU/L) during treatment.If permanent NH has not been confirmed by imaging or elevated TSH during treatment, consider a trial off levothyroxine at age 3 years.[12, 18, 21]Avoiding misdiagnosisPatients may be treated for years unnecessarily if the etiology is not recognized; a very high initial TSH (eg, 460 μIU/mL [SI: 460 mIU/L]) does not necessarily indicate permanent disease.Revisit dietary and cultural history if clinical course is atypical (eg, stable low-dose requirement); reassess diagnosis before assuming lifelong treatment is needed.[12, 18, 21]Abbreviations: AAP, American Academy of Pediatrics; LBW, low birthweight; NH, neonatal hypothyroidism; NICU, neonatal intensive care unit; TSH, thyroid-stimulating hormone. Key clinical takeaways and recommendations for iodine-induced neonatal hypothyroidism Abbreviations: AAP, American Academy of Pediatrics; LBW, low birthweight; NH, neonatal hypothyroidism; NICU, neonatal intensive care unit; TSH, thyroid-stimulating hormone. A limitation of this case series is that quantitative maternal iodine intake and breast milk iodine measurements were not obtained. Additionally, thyroid imaging was not obtained. Without imaging, thyroid dysgenesis, the most common cause of permanent CH, cannot be excluded [11]. Learning points Initial TSH severity is a poor predictor of permanence in NH; levothyroxine dose trajectory over time is more clinically reliable. Initial TSH severity is a poor predictor of permanence in NH; levothyroxine dose trajectory over time is more clinically reliable. A normal initial newborn screen does not exclude delayed NH when maternal seaweed soup consumption begins postpartum, as iodine accumulates in breast milk over time. A normal initial newborn screen does not exclude delayed NH when maternal seaweed soup consumption begins postpartum, as iodine accumulates in breast milk over time. Culturally sensitive history-taking about seaweed consumption should be incorporated into the evaluation of all infants with NH, particularly in East Asian families. Culturally sensitive history-taking about seaweed consumption should be incorporated into the evaluation of all infants with NH, particularly in East Asian families. Systematic reevaluation with a trial off levothyroxine at age 3 years should be considered when levothyroxine requirements do not escalate with growth, to prevent unnecessary lifelong therapy. Systematic reevaluation with a trial off levothyroxine at age 3 years should be considered when levothyroxine requirements do not escalate with growth, to prevent unnecessary lifelong therapy.